Approval · Notice of Compliance 38409 · 2026
PRO-NAPROXEN: Notice of Compliance 38409
Issued October 5, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38409
- Date
- October 5, 2026
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRO-NAPROXEN | 02572176 | Approved |
| PRO-NAPROXEN | 02572184 | Approved |
| PRO-NAPROXEN | 02572192 | Approved |
| PRO-NAPROXEN EC | 02572141 | Approved |
| PRO-NAPROXEN EC | 02572168 | Approved |
| PRO-NAPROXEN EC | 02310953 | Marketed |